title: Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing.
authors.forename: C T
authors.initials: CT
authors.lastname: Ng
authors.forename: B J
authors.initials: BJ
authors.lastname: Radovits
authors.forename: W
authors.initials: W
authors.lastname: Kievit
authors.forename: J
authors.initials: J
authors.lastname: Fransen
authors.forename: P L C M
authors.initials: PL
authors.lastname: van Riel
authors.forename: O
authors.initials: O
authors.lastname: FitzGerald
authors.forename: D J
authors.initials: DJ
authors.lastname: Veale
authors.forename: B
authors.initials: B
authors.lastname: Bresnihan
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D011307:Drug Prescriptions / Q000592:standards*; D005260:Female; D006801:Humans; D007494:Ireland; D007880:Legislation, Drug; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha